Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1)

The CJEU broadens the scope of European SPCs, but shortens validity of its duration in certain Member States




Julkaisun tekijät: Daniel Acquah

Kustantaja: Oxford University Press

Paikka: Oxford

Julkaisuvuosi: 2017

Journal: Journal of Intellectual Property Law and Practice

Lehden akronyymi: JIPLP

Volyymi: 12

Julkaisunumero: 4

Sivujen määrä: 2

ISSN: 1747-1532

eISSN: 1747-1540

DOI: http://dx.doi.org/10.1093/jiplp/jpx016

Verkko-osoite: https://academic.oup.com/jiplp/article/12/4/263/3065362/The-CJEU-broadens-the-scope-of-European-SPCs-but

Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/19260413


Tiivistelmä

The Court of Justice of the European Union (CJEU) has clarified that, where a medicinal product has been the subject of a marketing authorization (MA) within the European Economic Area (EEA), before that granted in a Member State of the European Union (EU), and even before the Member State’s accession to the EU, the EEA MA must be taken into account for the purpose of determining the duration of the supplementary protection certificate granted in the EU.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Last updated on 2022-07-04 at 16:25